| IASP | International Association for the Study of Pain |
| CNS | Central nervous system |
| PNS | Peripheral nervous system |
| HIV | Human immunodeficiency virus |
| COVID-19 | Coronavirus disease 2019 |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| GRADE | Grading of Recommendations Assessment, Development, and Evaluation |
| NeuPSIG | Special Interest Group on Neuropathic Pain |
| LNP | Localized neuropathic pain |
| PWT | Paw withdrawal threshold |
| PWL | Paw withdrawal latencies |
| CCI | Chronic constriction injury |
| SNL | Spinal nerve ligation |
| TWL | Tail withdrawal latencies |
| STZ | streptozotocin |
| H&E staining | Hematoxylin-eosin staining |
| Cmax | Mean peak concentration |
| Tmax | Mean peak time |
| T1/2 | Half-life |
| NLRP3 | NOD-like receptor protein 3 |
| MCC950 | A selective inhibitor of the NLRP3 inflammasome |
| ZDF | Zucker diabetic fatty |
| T2DM | Type 2 diabetes mellitus |
| HPLC-MS | High Performance Liquid Chromatography-Mass Spectrometry |
| ROS | Reactive oxygen species |
| MIA | Monoiodoacetate |
| AUC | Area under curve |
| PTX | Paclitaxel |
| TNF-α | Tumor Necrosis Factor-Alpha |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| UHPLC-MS | ultra-high-performance liquid chromatography tandem mass spectrometry |
| MMPs | Matrix metalloproteinases |
| T-AOC | Total antioxidant capacity |
| CAT | Catalase |
| T-SOD | Total superoxide dismutase |
| MAD | Malondialdehyde |
| NF-κB | Nuclear factor kappa B |
| Keap1 | Kelch-like ECH associated protein 1 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| ATP | Adenosine triphosphate |
| P2X7R | P2X receptor 7 |
| TRPA1 | Transient receptor potential ankyrin 1 |
| TRP | Transient receptor potential |
| HPS | High-throughput screening |
| GPCR | G-protein-coupled receptor |
| GRP160 | G-protein-coupled receptor 160 |
| GPR34 | G-protein-coupled receptor 34 |
| GPR40 | G-protein-coupled receptor 40 |
| GLP-1R | Glucagon-like peptide-1 receptor |
| CTAP | μ-Opioid receptor antagonist |
| POMC | β-Endorphin precursor proopiomelanocortin |
| C3G | Cyanidin-3-o-glucoside |
| RNS | Reactive nitrogen species |
| TRPM2 | Transient receptor potential melastatin 2 |
| TRPM3 | Transient receptor potential melastatin 3 |
| TRPM4 | Transient receptor potential melastatin 4 |
| TRPC3 | Transient receptor potential channel canonical 3 |
| TRPC4 | Transient receptor potential channel canonical 4 |
| TRPV1 | Transient receptor potential vanilloid type 1 |
| TRPV4 | Transient receptor potential vanilloid type 4 |
| RCS | Reactive carbonyl species |
| SP | Substance P |
| CGRP | Calcitonin gene-related peptide |